Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MPL | P40238 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.43 |
| ▸ | DHPS | P49366 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29803060 | 1.00 | SMN1; SMN2 (0.59) | SMN1; SMN2ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL17046876 | 0.84 | SMN1; SMN2 (0.71) | SMN1; SMN2ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL30468191 | 0.84 | SMN1; SMN2 (0.71) | SMN1; SMN2ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL6307067 | 0.82 | HSP90AA1 (0.69) | SMN1; SMN2ADORA2AADORA1MPLALDH1A1 | |
| SCHEMBL10822469 | 0.78 | SMN1; SMN2 (0.48) | SMN1; SMN2ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL9566504 | 0.77 | SMN1; SMN2 (0.63) | SMN1; SMN2ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL16388461 | 0.77 | CDK9 (0.47) | SMN1; SMN2ADORA2AADORA1ADORA2BALOX15 | |
| SCHEMBL9566587 | 0.76 | HRH4 (0.57) | SMN1; SMN2ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL9566537 | 0.75 | NPC1 (0.68) | SMN1; SMN2ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL22468017 | 0.74 | NPC1 (0.46) | SMN1; SMN2ADORA2AKDM4ENPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118126325-A | Low-temperature-cured alkali-soluble photosensitive resin and preparation method thereof | 深圳先进电子材料国际创新研究院 | 2024-06-04 | — | — | CN | claimed |
| WO-2024046225-A1 | ESTER TYPE PHOTOSENSITIVE POLYIMIDE COMPOSITE MATERIAL, PREPARATION METHOD AND SEMICONDUCTOR APPARATUS | 深圳先进电子材料国际创新研究院 | 2024-03-07 | — | — | WO | claimed |
| CN-114805805-B | Polyimide with high adhesive strength and preparation method and application thereof | 深圳先进电子材料国际创新研究院 | 2023-12-19 | — | — | CN | claimed |
| CN-115509088-A | Ester type photosensitive polyimide composite material, preparation method and semiconductor device | 深圳先进电子材料国际创新研究院 | 2022-12-23 | — | — | CN | claimed |
| CN-114805805-A | Polyimide with high bonding strength and preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2022-07-29 | — | — | CN | claimed |
| US-7081273-B2 | Preparing coating solutions, coating on substrarte; applying vacuum; coagulating; removing solvent and additives from membrane in a series of leaching baths stirred with submersible ultrasonic cleaner;controlling and monitoring coating thickness ; collecting membrane; curing | ACCORD PARTNER LIMITED (VG) | 2006-07-25 | — | — | US | claimed |
| US-20060000766-A1 | Method for producing defect free composite membranes | ACCORD PARTNER LIMITED (VG) | 2006-01-05 | — | — | US | claimed |
| CN-118126325-A | Low-temperature-cured alkali-soluble photosensitive resin and preparation method thereof | 深圳先进电子材料国际创新研究院 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024046225-A1 | ESTER TYPE PHOTOSENSITIVE POLYIMIDE COMPOSITE MATERIAL, PREPARATION METHOD AND SEMICONDUCTOR APPARATUS | 深圳先进电子材料国际创新研究院 | 2024-03-07 | — | — | WO | disclosed |
| CN-114805805-B | Polyimide with high adhesive strength and preparation method and application thereof | 深圳先进电子材料国际创新研究院 | 2023-12-19 | — | — | CN | disclosed |
| US-11844802-B2 | Compounds and compositions for ossification and methods related thereto | EMORY UNIVERSITY (US) | 2023-12-19 | — | — | US | disclosed |
| US-20230044670-A1 | Compounds and Compositions for Ossification and Methods Related Thereto | UNIV EMORY (US) | 2023-02-09 | — | — | US | disclosed |
| CN-115509088-A | Ester type photosensitive polyimide composite material, preparation method and semiconductor device | 深圳先进电子材料国际创新研究院 | 2022-12-23 | — | — | CN | disclosed |
| US-9511071-B2 | Compounds and compositions for ossification and methods related thereto | EMORY UNIVERSITY (US) | 2016-12-06 | — | — | US | disclosed |
| EP-2605804-A2 | COMPOUNDS AND COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO | Emory University (US) | 2013-06-26 | — | — | EP | disclosed |
| US-20130137634-A1 | COMPOUNDS AND COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO | EMORY UNIVERSITY (US) | 2013-05-30 | — | — | US | disclosed |
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| WO-2012024489-A2 | COMPOUNDS AND COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO | EMORY UNIVERSITY (US) | 2012-02-23 | — | — | WO | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |
| EP-0563386-A1 | ANTICANCER COMPOSITION AND COMPOUND | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1993-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130137634-A1 | COMPOUNDS AND COMPOSITIONS FOR OSSIFICATION AND METHODS RELATED THERETO | BMP2, SOST, BMP4 | SMN1; SMN2 2252/4885ADORA2A 181/4885ADORA1 432/4885 |
| US-20230044670-A1 | Compounds and Compositions for Ossification and Methods Related Thereto | BMP2, SOST, BMP4 | SMN1; SMN2 2252/4885ADORA2A 181/4885ADORA1 432/4885 |
| US-11844802-B2 | Compounds and compositions for ossification and methods related thereto | BMP2, SOST, BMP4 | SMN1; SMN2 2252/4885ADORA2A 181/4885ADORA1 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.